NanoRepro Stock
NanoRepro AG
Company data
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- Germany
- CEO
- Lisa Jungst
- Employees
- 22
- Market cap
- €24 M
- IPO
- 22/10/2009
Based in Marburg, Germany, NanoRepro AG operates within the Healthcare sector and specializes in the development, manufacturing, and international distribution of rapid diagnostic tests and nutritional supplements. The company serves both individual consumers and healthcare professionals through its diverse product…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
NanoRepro stock: price history
1D
+0.0%
1W
+0.0%
1M
-0.6%
6M
+16.1%
YTD
+14.6%
1Y
-0.6%
2Y
-2.8%
5Y
-78.4%
10Y
+85.9%
Next earnings date
Next earnings date
14/05/2027 (in 209 days)
Volatility around earnings
~10% weaker price swings than usual
Ask the agents about NanoRepro
NanoRepro stock metrics
P/E
-10.95
P/B
0.6
EV/EBITDA
-7.75
RETURN ON EQUITY
-3.2%
NET MARGIN
-59.9%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
31/12/2025
Free float & liquidity
FREE FLOAT
93.1%
FLOAT SHARES
12,948,245
AVG. DAILY VOLUME (30D)
6,803
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about NanoRepro stock
What does NanoRepro do?
NanoRepro AG is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in Germany.
The CEO is Lisa Jungst, the company employs around 22 people.
The IPO was on 22/10/2009; the stock trades on XETRA under the ticker NN6.DE.
When does NanoRepro report next?
The next earnings date is 14/05/2027.
Around past earnings, price swings were roughly -10% stronger than usual.
Does NanoRepro pay a dividend?
Yes. The last dividend was €0.15 per share, ex-date 16/06/2023, paid on 20/06/2023.
The dividend yield is 0.0% (as of 31/12/2025).
Which stocks are comparable to NanoRepro?
Comparable stocks include Thermo Fisher Scientific, Danaher, Natera, Agilent Technologies, IQVIA Holdings, Waters, Illumina and IDEXX Laboratories.
How can I get NanoRepro stock analyzed?
Clicking "Analyze stock" lets five strategies assess NanoRepro against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.